JAK2 and myeloid sarcoma: O’Doherty and colleagues analysed 61 relevant SNPs in 155 responding and 100 non-responding Irish MS patients and found a JAK2–IL10–CASP3 allelic combination to be predictive of response status (p-value = 4.0×10−4) [59].